Bluebird Bio, a clinical-stage biotechnology company, raises $116.1m on Nasdaq.

PTC Therapeutics, a US-based drugs developer for muscles, raises $144.4m on Nasdaq.

Pharmaceutical company Mylan leads $12m series 2 preferred financing for diagnostics company.

Centice, a biotech spin-out of Duke University, receives slice of $7m venture funding from QWave Fund.

Stanford spin-out NuMedii closes $3.5m series A for big data pharma platform.

Molecular diagnostics company Veracyte raises $28m C funding with GE Ventures as a new investor.

Johnson & Johnson Development Corporation and Atlas Venture back biotechnology, neuroscience startup.